PBHNYSEPharmaceutical PreparationsFiscal year ends March 31

Prestige Consumer Healthcare Inc.

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$49.71−0.21 (-0.42%)

Close on Oct 19, 2026

Community

Notes and questions about Prestige Consumer Healthcare from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Prestige Consumer Healthcare's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PBH.

Revenue growth-1.4% · median 9.3%

Gross margin53.5% · median 39.3%

Operating margin26.3% · median 12.8%

Net margin15.6% · median 5.0%

Advertisement
300 × 250